Low-dose zinc administration as an effective Wilson's disease treatment

Biological Trace Element Research

Volumn 80, Issue 3, 2001, Pages 281-284

  Najda, J ^a   Stella Holowiecka, B ^a   Machalski, M ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Copper; Wilson's disease; Zinc

Indexed keywords

ZINC;

ADOLESCENT; ARTICLE; CASE REPORT; CLINICAL FEATURE; COPPER METABOLISM; DOSE RESPONSE; DRUG EFFICACY; HUMAN; KIDNEY CLEARANCE; MALE; REMISSION; WILSON DISEASE;

ADOLESCENT; ADULT; COPPER; HEPATOLENTICULAR DEGENERATION; HUMANS; MALE; TIME FACTORS; ZINC;

EID: 0034895360     PISSN: 01634984     EISSN: None     Source Type: Journal    
DOI: 10.1385/BTER:80:3:281     Document Type: Article

References (15)

1. Wilson disease
2. The Wilson disease gene is a putative copper transporting P-type ATP-ase similar to the Menkes gene
3. Mapping, cloning and genetic characterization of the region containing the Wilson disease gene
4. Pathogenese des Morbus Wilson
5. Wilson's disease: Clinical presentation, treatment and survival
6. The outlook for the diagnosis of Wilson's disease
7. Practical recommendations and new therapies for Wilson's disease
8. Therapie des Morbus Wilson
9. Standarisation of ceruloplasmin activity in terms of international units. Oxidative formation of Bandrowski base from p-phenylenediamine by ceruloplasmin
10. The treatment of Wilson's disease with zinc. Intestinal metallothionein induction
11. The effect of dietary zinc on intestinal copper absorption
12. Zinc therapy in Wilson's disease - Observations in five patients
13. Zinc therapy of Wilson's disease; VIII - Dose response studies
14. The treatment of Wilson's disease with zinc; IV. Efficacy monitoring using urine and plasma copper